Solstein Capital’s Dillards DDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249K Hold
435
0.1% 120
2025
Q4
$264K Hold
435
0.11% 116
2025
Q3
$267K Hold
435
0.06% 108
2025
Q2
$182K Hold
435
0.09% 115
2025
Q1
$156K Hold
435
0.09% 108
2024
Q4
$188K Hold
435
0.11% 102
2024
Q3
$167K Hold
435
0.09% 110
2024
Q2
$192K Hold
435
0.13% 93
2024
Q1
$205K Hold
435
0.14% 89
2023
Q4
$176K Hold
435
0.13% 94
2023
Q3
$144K Hold
435
0.12% 96
2023
Q2
$142K Hold
435
0.12% 102
2023
Q1
$134K Hold
435
0.12% 102
2022
Q4
$141K Hold
435
0.12% 114
2022
Q3
$119K Hold
435
0.1% 105
2022
Q2
$96K Hold
435
0.07% 136
2022
Q1
$117K Hold
435
0.08% 143
2021
Q4
$107K Hold
435
0.06% 155
2021
Q3
$75K Hold
435
0.04% 202
2021
Q2
$79K Sell
435
-1,865
-81% -$240K 0.1% 180
2021
Q1
$222K Buy
+2,300
New +$187K 0.3% 88
2020
Q1
Sell
-174
Closed -$13K 293
2019
Q4
$13K Buy
+174
New +$12.3K 0.03% 240

Other funds holding DDS

Solstein Capital's DDS Position: Q1 2026 in Review

Solstein Capital held its Dillards (DDS) position steady in Q1 2026 at 435 shares worth $249K. The position accounts for 0.1% of the portfolio, ranked #120.

Solstein Capital first reported a position in DDS in Q4 2019 and has held it in 22 quarters since. The position peaked at $267K in Q3 2025. 316 funds tracked by Wall St. Rank hold DDS as of Q1 2026.

  • Solstein Capital held 435 shares of Dillards worth $249K as of Q1 2026.
  • Solstein Capital left its Dillards share count unchanged in Q1 2026.
  • Dillards made up 0.1% of Solstein Capital's portfolio in Q1 2026, its #120 holding.
  • Solstein Capital first reported a position in Dillards in Q4 2019 and has held it in 22 quarters since.
  • Solstein Capital's Dillards position peaked at $267K in Q3 2025.
  • 316 funds tracked by Wall St. Rank held Dillards as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.